The history of the erectile dysfunction drug presents a challenging picture for investors. While the initial launch generated significant profits, the end of its exclusive rights opened the avenue to generic versions, https://yxzbookmarks.com/story21645980/sildenafil-and-pharma-a-precarious-bet